BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35654593)

  • 1. Surveillance of Unruptured Intracranial Aneurysms: Cost-Effectiveness Analysis for 3 Countries.
    Cras TY; Hunink MMG; Dammers R; van Es ACGM; Volovici V; Burke JF; Kremers FCC; Dippel DWJ; Roozenbeek B
    Neurology; 2022 Aug; 99(9):e890-e903. PubMed ID: 35654593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Tiny Unruptured Intracranial Aneurysms: A Comparative Effectiveness Analysis.
    Malhotra A; Wu X; Forman HP; Matouk CC; Gandhi D; Sanelli P
    JAMA Neurol; 2018 Jan; 75(1):27-34. PubMed ID: 29159405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Unruptured Intracranial Aneurysms in Older Adults: A Cost-effectiveness Analysis.
    Malhotra A; Wu X; Forman HP; Matouk CC; Hughes DR; Gandhi D; Sanelli P
    Radiology; 2019 May; 291(2):411-417. PubMed ID: 30888931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pipeline embolization device versus coiling for the treatment of large and giant unruptured intracranial aneurysms: a cost-effectiveness analysis.
    Wali AR; Park CC; Santiago-Dieppa DR; Vaida F; Murphy JD; Khalessi AA
    Neurosurg Focus; 2017 Jun; 42(6):E6. PubMed ID: 28565986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging versus Intervention in Managing Small Unruptured Intracranial Aneurysms: A Cost-Effectiveness Analysis.
    Veet CA; Capone S; Panczykowski D; Parekh N; Smith KJ; Kim DH; Choi HA; Blackburn SL
    Cerebrovasc Dis; 2022; 51(3):338-348. PubMed ID: 34758465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Computed Tomography Angiography in Management of Tiny Unruptured Intracranial Aneurysms in the United States.
    Wu X; Matouk CC; Mangla R; Forman HP; Gandhi D; Sanelli P; Malhotra A
    Stroke; 2019 Sep; 50(9):2396-2403. PubMed ID: 31340732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneurysm growth and de novo aneurysms during aneurysm surveillance.
    Serrone JC; Tackla RD; Gozal YM; Hanseman DJ; Gogela SL; Vuong SM; Kosty JA; Steiner CA; Krueger BM; Grossman AW; Ringer AJ
    J Neurosurg; 2016 Dec; 125(6):1374-1382. PubMed ID: 26967775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Intracranial Aneurysms in Coarctation of the Aorta: A Decision and Cost-Effectiveness Analysis.
    Pickard SS; Prakash A; Newburger JW; Malek AM; Wong JB
    Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006406. PubMed ID: 32762482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom.
    Hall S; Abouharb A; Anderson I; Bacon A; Bahl A; Brydon H; Dow G; Fouyas I; Galea J; Ghosh A; Gurusinghe N; Kamel M; Minhas P; Mitchell P; Mowle D; Mukerji N; Nair R; Norris J; Patel H; Patel J; Patel K; St George J; Teo M; Toma A; Trivedi R; Uff C; Visca A; Walsh DC; White E; Whitfield P; Bulters D
    Br J Neurosurg; 2023 Apr; 37(2):163-169. PubMed ID: 34738491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis on small (< 5 mm) unruptured intracranial aneurysm follow-up strategies.
    Salih M; Salem M; Moore J; Thomas AJ; Ogilvy CS
    J Neurosurg; 2023 May; 138(5):1366-1373. PubMed ID: 36208436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and rupture of unruptured intracranial aneurysms.
    Juvela S
    J Neurosurg; 2018 Sep; 131(3):843-851. PubMed ID: 30215563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis.
    Johnston SC; Gress DR; Kahn JG
    Neurology; 1999 Jun; 52(9):1806-15. PubMed ID: 10371527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovation in unruptured intracranial aneurysm coiling: At which price or efficacy are new technologies cost-effective?
    Ben-Israel D; Belanger BL; Adibi A; Eesa M; Mitha AP; Spackman E
    PLoS One; 2021; 16(8):e0255870. PubMed ID: 34370777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of WEB Embolization, Coiling and Stent-assisted Coiling for the Treatment of Unruptured Intracranial Aneurysms.
    Goertz L; Simões Corrêa Galendi J; Kabbasch C; Schlamann M; Pennig L; Froelich MF; Timmer M; Liebig T; Stock S; Mueller D; Große Hokamp N
    Clin Neuroradiol; 2023 Dec; 33(4):1075-1086. PubMed ID: 37368089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness analysis of Pipeline device versus coiling in unruptured aneurysms smaller than 10 mm.
    Malhotra A; Wu X; Miller T; Matouk CC; Sanelli P; Gandhi D
    J Neurosurg; 2019 Jan; 132(1):42-50. PubMed ID: 30641830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of postoperative imaging surveillance strategies for nonfunctional pituitary adenomas after resection with curative intent.
    Caulley L; Dijk SW; Krijkamp E; Dong SX; Alkherayf F; Amrani L; Doyle MA; Eid A; Johnson-Obaseki S; Khoury M; Malcolm J; Mavedatnia D; Sahlollbey N; Schramm D; Whelan J; Thavorn K; Kilty S; Hunink MGM
    J Neurosurg; 2023 Nov; 139(5):1207-1215. PubMed ID: 37922550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
    Sun L; Brentnall A; Patel S; Buist DSM; Bowles EJA; Evans DGR; Eccles D; Hopper J; Li S; Southey M; Duffy S; Cuzick J; Dos Santos Silva I; Miners A; Sadique Z; Yang L; Legood R; Manchanda R
    JAMA Oncol; 2019 Dec; 5(12):1718-1730. PubMed ID: 31580391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis.
    King JT; Glick HA; Mason TJ; Flamm ES
    J Neurosurg; 1995 Sep; 83(3):403-12. PubMed ID: 7666214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
    Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
    JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.